Table 2 Results of surgery (no significant differences)
Characteristic | Neoadjuvant chemotherapy (n = 26) | Primary surgery (n = 26) |
|---|---|---|
Total hysterectomy (%) | 22 (85) | 23 (88) |
Bilateral salpingo-oophorectomy (%) | 25 (96) | 26 (100) |
Omentectomy (%) | 24 (92) | 24 (92) |
Rectosigmoid resection (%) | 5 (19) | 8 (31) |
Multiple bowel resection (%) | 1 (4) | 1 (4) |
Cytology of ascites (%) | ||
Positive | 8 (42) | 14 (54) |
Negative | 11 (58) | 12 (46) |
ND | 7 | 0 |
Lymphadenectomies (%) | 13 (50) | 17 (65) |
Median lymph nodes removed (range) | 25 (10 – 50) | 23 (4 – 50) |
Median lymph nodes involved (range) | 1 (0 – 4) | 2 (0 – 14) |
Median ratio involved/removed (range) | 4 (0 – 36) | 7 (0 – 57) |
Complete cytoreduction | 19 (73) | 14 (54) |
Residual tumour (%) | ||
≤ 1 cm | 2 (8) | 4 (15) |
1.1 – 2 cm | 1 (4) | 2 (8) |
> 2 cm | 4 (15) | 6 (23) |
Location of residual tumour* (%) | ||
Pelvis | 2 (15) | 3 (19) |
Upper abdomen | 6 (46) | 6 (37.5) |
Peritoneal, extensive | 4 (31) | 6 (37.5) |
Retroperitoneal | 1 (8) | 1 (6) |